Atıf Formatları
Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. ŞANLIOĞLU Et Al. , "Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer," 1st International Multidisciplinary Cancer Research Congress , Antalya, Turkey, pp.8, 2009

ŞANLIOĞLU, S. Et Al. 2009. Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer. 1st International Multidisciplinary Cancer Research Congress , (Antalya, Turkey), 8.

ŞANLIOĞLU, S., Bişgin, A., Yalçın, A., aydın, ç., ekinci, d., TERZİOĞLU, M. E., ... Savaş, B.(2009). Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer . 1st International Multidisciplinary Cancer Research Congress (pp.8). Antalya, Turkey

ŞANLIOĞLU, SALİH Et Al. "Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer," 1st International Multidisciplinary Cancer Research Congress, Antalya, Turkey, 2009

ŞANLIOĞLU, SALİH Et Al. "Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer." 1st International Multidisciplinary Cancer Research Congress , Antalya, Turkey, pp.8, 2009

ŞANLIOĞLU, S. Et Al. (2009) . "Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer." 1st International Multidisciplinary Cancer Research Congress , Antalya, Turkey, p.8.

@conferencepaper{conferencepaper, author={SALİH ŞANLIOĞLU Et Al. }, title={Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer}, congress name={1st International Multidisciplinary Cancer Research Congress}, city={Antalya}, country={Turkey}, year={2009}, pages={8} }